Bio-Techne Corporation (TECH) is a global life sciences company headquartered in Minneapolis that develops, manufactures, and ...

Activist investor Ananym Capital Management has built a stake in Bio-Techne Corp. and is pushing the board to conduct a ...

Bio-Techne rose 4% on a report that activist investor Ananym Capital Management has accumulated a stake in the maker of ...

View Bio-Techne Corporation TECH stock quote prices, financial information, real-time forecasts, and company news from CNN.

Bio-Techne (TECH) has drawn fresh investor interest after teaming up with Refeyn on a four hour integrated workflow that links charge heterogeneity, molecular weight, and aggregation in bispecific ...

TECH is set to post Q2 results on Feb. 4, with EPS expected at 43 cents and revenues seen at $292 million. TECH faces Q2 uncertainty from tariffs and NIH budget cuts, with cell therapy timing weighing ...

Is TECH a good stock to buy? We came across a bullish thesis on Bio-Techne Corporation on r/ValueInvesting by Dynaheir-be. In ...

Hollow Brook Wealth Management sold its entire position in Bio-Techne -- 174,677 shares -- during the fourth quarter of 2025, for an estimated $10.7 million based on quarterly average pricing. The ...

Bio-Techne (TECH Quick Quote TECH - Free Report) reported second-quarter fiscal 2025 adjusted earnings per share (EPS) of 42 cents, which exceeded the Zacks Consensus Estimate by 10.5%. The bottom ...

ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In an ...

RBC Capital on Tuesday upgraded Bio-Techne Corporation (NASDAQ:TECH), noting that recent end-market weakness has over-penalized one of the best assets in the life science and tools (LST) sector, ...

Bio‑Techne Corporation, a global provider of life science tools, reagents and diagnostic products, and Refeyn, the pioneer in mass photometry technology, today announced a first‑of‑its‑kind integrated ...